Tiejun Bing
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Nanoplatforms for cancer theranostics
Papers in
-
- RNA modifications and cancer 3
-
- Nanoplatforms for cancer theranostics 5
- Ultrasound and Hyperthermia Applications 2
- Co-authors
- Yingjie Yu (7 shared papers)Yujing Tang (2 shared papers)Meifang Shen (5 shared papers)Haihua Xiao (4 shared papers)Chaoyong Liu (2 shared papers)Xueyi Liu (2 shared papers)Yushu Wang (1 shared paper)Jia Huang (1 shared paper)
- Journals
- Advanced Functional Materials (3 papers)Journal of Medicinal Chemistry (2 papers)Advanced Science (2 papers)Advanced Materials (2 papers)Virus Genes (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Tiejun Bing
12 papers receiving 299 citations
Tiejun Bing's Hit Papers
Peers
Comparison fields: 5 of 62
- Biomaterials 57
- Biomedical Engineering 140
- Immunology 55
- Physiology 9
- Virology 9
Countries citing papers authored by Tiejun Bing
This map shows the geographic impact of Tiejun Bing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiejun Bing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiejun Bing more than expected).
Fields of papers citing papers by Tiejun Bing
This network shows the impact of papers produced by Tiejun Bing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiejun Bing. The network helps show where Tiejun Bing may publish in the future.
Co-authors
The 25 scholars most cited alongside Tiejun Bing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 77 | |
| 2 | Stimulus‐Responsive Copper Complex Nanoparticles Induce Cuproptosis for Augmented Cancer Immunotherapy Hit paper breakdown → | 2024 | 62 |
| 3 | 2023 | 52 | |
| 4 | 2024 | 34 | |
| 5 | 2024 | 31 | |
| 6 | 2024 | 18 | |
| 7 | 2014 | 8 | |
| 8 | 2019 | 7 | |
| 9 | 2025 | 5 | |
| 10 | 2014 | 3 | |
| 11 | 2025 | 3 | |
| 12 | 2025 | 1 | |
| 13 | 2025 | 0 | |
| 14 | 2025 | 0 |
About Tiejun Bing
Tiejun Bing is a scholar working on Molecular Biology, Biomedical Engineering, Animal Science and Zoology, Oncology and Agronomy and Crop Science, having authored 14 papers that have together received 301 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (5 papers), RNA modifications and cancer (3 papers), MicroRNA in disease regulation (2 papers), Animal Disease Management and Epidemiology (2 papers), Animal Virus Infections Studies (2 papers), Ultrasound and Hyperthermia Applications (2 papers), Virus-based gene therapy research (2 papers) and interferon and immune responses (1 paper). The work is most often cited by research in Biomaterials (57 citations), Biomedical Engineering (140 citations), Immunology (55 citations), Physiology (9 citations) and Virology (9 citations). Tiejun Bing has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yingjie Yu, Yujing Tang, Meifang Shen, Haihua Xiao, Chaoyong Liu, Xueyi Liu, Yushu Wang, Jia Huang, Yushu Wang and Hanchen Zhang. Their work appears in journals such as Advanced Functional Materials, Journal of Medicinal Chemistry, Advanced Science, Advanced Materials and Virus Genes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.